Cordyceps Sunshine Biotech Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Cordyceps Sunshine Biotech Holdings has a total shareholder equity of $-78.7K and total debt of $445.3K, which brings its debt-to-equity ratio to -565.6%. Its total assets and total liabilities are $3.4M and $3.5M respectively. Cordyceps Sunshine Biotech Holdings's EBIT is $225.4K making its interest coverage ratio 8.5. It has cash and short-term investments of $15.3K.
Anahtar bilgiler
-565.6%
Borç/özkaynak oranı
US$445.28k
Borç
| Faiz karşılama oranı | 8.5x |
| Nakit | US$15.28k |
| Eşitlik | -US$78.73k |
| Toplam yükümlülükler | US$3.50m |
| Toplam varlıklar | US$3.42m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: RAJA.F has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: RAJA.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Borç Kapsamı: RAJA.F's debt is well covered by operating cash flow (72.9%).
Faiz Kapsamı: RAJA.F's interest payments on its debt are well covered by EBIT (8.5x coverage).